Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Urinary Bladder Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Mesothelioma, Malignant 1Melanoma 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 3durvalumab 2belinostat 2obinutuzumab 1naptumomab estafenatox 1entinostat 1cemiplimab 1bosutinib 1avelumab 1atezolizumab 1Sirolimus 1Quality of Life 1Polymerase Chain Reaction 1Pemetrexed 1Patient Reported Outcome Measures 1Nivolumab 1Molecular Diagnostic Techniques 1Microarray Analysis 1Interleukin-2 1In Situ Hybridization, Fluorescence 1Immunotherapy 1Immunoenzyme Techniques 1Immune Checkpoint Inhibitors 1Gene Expression Profiling 1Fluorouracil 1Fluorodeoxyglucose F18 1Flow Cytometry 1Fentanyl 1Erlotinib Hydrochloride 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × In Situ Hybridization, Fluorescence × Other solid neoplasm × Clear all
NCT07403630 2026-02-17

IT-TCP POS

Azienda Ospedaliero-Universitaria di Parma

Phase NA Recruiting
300 enrolled
DermatologicGastrointestinalGenitourinaryGynecologicLymphoidMyeloidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Carcinoma, Squamous Cell, Melanoma, Multiple Myeloma, Myeloproliferative Disorders, Ovarian Neoplasms, Pancreatic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡